United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average
Sector average (own scale)
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for IN8BIO, INC.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| ROE | -92.49% | -109.11% | - | 92.28% | 47.98% | 32.53% |
|---|---|---|---|---|---|---|
| Sector average | 20.42% | 71.17% | 5.82% | 58.79% | 17.46% | 2.74% |
| ROA | -73.05% | -86.26% | -623.32% | 124.71% | 79.1% | 79.42% |
| Total Assets | $32,282.00K | $12,826.65K | - | - | - | - |
| Sector average | $3,280,499.23K | $3,298,345.31K | $3,676,894.01K | |||
| Net Income | -$19,440.00K | -$19,455.35K | -$19,421.66K | -$19,392.86K | -$19,384.45K | -$19,463.92K |
| $4,262,561.28K |
| $4,994,412.92K |
| $5,761,557.24K |